Amundi
ONC icon

Amundi’s BeOne Medicines Ltd ONC Stock Holding History

Amundi’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,570
Closed -$232K – 2026
2024
Q2 		$232K Buy
1,570
+1,274
+430% +$196K ﹤0.01% 1543
2024
Q1 		$39.1K Buy
296
+137
+86% +$22.1K ﹤0.01% 1864
2023
Q4 		$28.9K Sell
159
-35
-18% -$6.33K ﹤0.01% 1930
2023
Q3 		$34.7K Buy
194
+73
+60% +$14.4K ﹤0.01% 1901
2023
Q2 		$21.9K Sell
121
-678
-85% -$156K ﹤0.01% 1956
2023
Q1 		$169K Sell
799
-54,030
-99% -$13M ﹤0.01% 1613
2022
Q4 		$13.9M Sell
54,829
-39,610
-42% -$7.26M 0.01% 781
2022
Q3 		$13.6M Buy
94,439
+6,760
+8% +$1.16M 0.01% 774
2022
Q2 		$15.4M Sell
87,679
-2,910
-3% -$455K 0.01% 678
2022
Q1 		$19.3M Buy
90,589
+1,420
+2% +$302K 0.01% 674
2021
Q4 		$21.1M Sell
89,169
-5,662
-6% -$1.91M 0.01% 666
2021
Q3 		$34.4M Buy
94,831
+1,249
+1% +$408K 0.02% 536
2021
Q2 		$32.1M Buy
+93,582
New +$31M 0.02% 552

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Amundi's ONC Position: Q3 2024 in Review

Amundi sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 1,570 shares — an estimated $232K sold.

Amundi first reported a position in ONC in Q2 2021 and held it in 13 quarters. The position peaked at $34.4M in Q3 2021. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Amundi reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Amundi sold 1,570 BeOne Medicines Ltd shares in Q3 2024, an estimated $232K.
  • Amundi first reported a position in BeOne Medicines Ltd in Q2 2021 and held it in 13 quarters.
  • Amundi's BeOne Medicines Ltd position peaked at $34.4M in Q3 2021.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Amundi's 13F filing for Q3 2024, filed 13 Nov 2024.